1naresh
Array
(
    [urn:ac.highwire.org:guest:identity] => Array
        (
            [runtime-id] => urn:ac.highwire.org:guest:identity
            [type] => guest
            [service-id] => ajnr-ac.highwire.org
            [access-type] => Controlled
            [privilege] => Array
                (
                    [urn:ac.highwire.org:guest:privilege] => Array
                        (
                            [runtime-id] => urn:ac.highwire.org:guest:privilege
                            [type] => privilege-set
                            [privilege-set] => GUEST
                        )

                )

            [credentials] => Array
                (
                    [method] => guest
                )

        )

)
1naresh
Array
(
    [urn:ac.highwire.org:guest:identity] => Array
        (
            [runtime-id] => urn:ac.highwire.org:guest:identity
            [type] => guest
            [service-id] => ajnr-ac.highwire.org
            [access-type] => Controlled
            [privilege] => Array
                (
                    [urn:ac.highwire.org:guest:privilege] => Array
                        (
                            [runtime-id] => urn:ac.highwire.org:guest:privilege
                            [type] => privilege-set
                            [privilege-set] => GUEST
                        )

                )

            [credentials] => Array
                (
                    [method] => guest
                )

        )

)


Table 1: 
Analysis of enhancement kinetics: BPA versus SCA
CategoryBPASCAP Value
Presence of uncontaminated arterial phase,a %68 ± 4768 ± 471
Peak arterial phaseb (sub)6.96 ± 1.636.15 ± 1.84.023
Peak arterial phaseb (unsub)6.96 ± 1.636.15 ± 1.84.023
Peak venous phaseb (sub)8.52 ± 1.648.0 ± 1.68.123
Peak venous phaseb (unsub)8.52 ± 1.648.0 ± 1.68.123
Peak venous–peak arterial phaseb (sub)1.56 ± 1.071.88 ± 1.19.161
Peak venous–peak arterial phaseb (unsub)1.56 ± 1.071.86 ± 1.18.186
  • Note:—All values are reported as mean ± standard deviation; sub, unsub reflect background subtracted and nonsubtracted volumes.
  • ↵a Percentage of cases with uncontaminated arteriographic phase (see text).
  • ↵b Expressed in terms of average, time-resolved phase number.